Medicskin Holdings Ltd. (HK:8307)

:8307

8307

Medicskin Holdings Ltd.

RESEARCH TOOLSreports

Want to see HK:8307 full AI Analyst Report?

Medicskin Holdings Ltd. (8307) Price & Analysis

0 Followers

8307 Stock Chart & Stats

HK$0.17

HK$0.00(0.00%)

At close: Nov 11 4:00 PM EST

HK$0.17

HK$0.00(0.00%)

Day’s Range― - ―

52-Week RangeHK$0.02 - HK$0.24

Previous CloseN/A

Volume16.00K

Average Volume (3M)24.27K

Market Cap

HK$56.73M

Enterprise ValueHK$51.47M

Total Cash (Recent Filing)HK$25.16M

Total Debt (Recent Filing)HK$19.89M

Price to Earnings (P/E)362.7

Beta0.83

Next Earnings

Jun 22, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.00

Shares Outstanding396,736,000

10 Day Avg. Volume55,600

30 Day Avg. Volume24,266

Financial Highlights & Ratios

PEG Ratio-2.09

Price to Book (P/B)17.50

Price to Sales (P/S)1.63

P/FCF Ratio8.86

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Operating Cash Flow ImprovementThe rise in operating cash flow to HKD 9.13M demonstrates durable liquidity generation that supports day-to-day operations, funds necessary capex and working capital, and extends runway while the company works toward profitability. This reduces short-term refinancing pressure and underpins operational continuity.

Strong Free Cash Flow ConversionRobust free cash flow conversion, even with accounting losses, indicates effective cash management and core business cash generation. That structural cash resilience improves ability to service debt, invest selectively, and sustain operations during revenue slippage, providing financial flexibility over coming quarters.

Stable/improving EBITDA MarginA modest improvement in EBITDA margin signals underlying operational efficiency and cost control in core services. Sustained mid-teens EBITDA margins provide a platform to scale profitably if revenue stabilizes, helping bridge toward breakeven and making fixed-cost absorption more manageable long-term.

Bears Say

High Financial LeverageExtremely high leverage and a thin equity base materially increase solvency and refinancing risk. With limited equity cushion, adverse cash shocks or higher funding costs could impair operations or force dilutive financing; this constrains strategic flexibility and heightens long-term financial vulnerability.

Sharp Gross Margin DeclineA significant drop in gross margin points to rising input costs or pricing pressure that erodes fundamental profitability. Persisting margin deterioration undermines the company’s ability to cover fixed costs and invest in growth; reversing this trend is critical for sustainable earnings recovery.

Revenue Contraction And Sustained LossesDeclining revenues coupled with multi-year negative net margins indicate structural demand or competitive issues and an extended path to profitability. Continued top-line weakness reduces leverage on fixed costs and makes reliance on cash reserves or external funding more likely, pressuring long-term viability.

8307 FAQ

What was Medicskin Holdings Ltd.’s price range in the past 12 months?

Medicskin Holdings Ltd. lowest stock price was HK$0.02 and its highest was HK$0.24 in the past 12 months.

What is Medicskin Holdings Ltd.’s market cap?

Medicskin Holdings Ltd.’s market cap is HK$56.73M.

When is Medicskin Holdings Ltd.’s upcoming earnings report date?

Medicskin Holdings Ltd.’s upcoming earnings report date is Jun 22, 2026 which is in 54 days.

How were Medicskin Holdings Ltd.’s earnings last quarter?

Medicskin Holdings Ltd. released its earnings results on Nov 24, 2025. The company reported HK$0 earnings per share for the quarter, the consensus estimate of N/A by HK$0.

Is Medicskin Holdings Ltd. overvalued?

According to Wall Street analysts Medicskin Holdings Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Medicskin Holdings Ltd. pay dividends?

Medicskin Holdings Ltd. pays a Notavailable dividend of HK$0.025 which represents an annual dividend yield of N/A. See more information on Medicskin Holdings Ltd. dividends here

What is Medicskin Holdings Ltd.’s EPS estimate?

Medicskin Holdings Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Medicskin Holdings Ltd. have?

Medicskin Holdings Ltd. has 396,736,000 shares outstanding.

What happened to Medicskin Holdings Ltd.’s price movement after its last earnings report?

Medicskin Holdings Ltd. reported an EPS of HK$0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went down -23.684%.

Which hedge fund is a major shareholder of Medicskin Holdings Ltd.?

Currently, no hedge funds are holding shares in HK:8307

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Medicskin Holdings Ltd.

Medicskin Holdings Ltd. (8307) is a leading healthcare company specializing in advanced dermatological and aesthetic solutions. The company operates in the medical and cosmetic sectors, offering a range of products and services designed to enhance skin health and appearance. Medicskin is known for its innovative skincare products, medical devices, and aesthetic treatments, catering to both consumers and healthcare professionals.